The effect of copper deficiency on fetal growth and liver anti-oxidant capacity in the Cohen diabetic rat model

Toxicology and Applied Pharmacology

Volumn 265, Issue 2, 2012, Pages 209-220

  Ergaz, Zivanit ^a   Shoshani Dror, Dana ^a   Guillemin, Claire ^b   Neeman azulay, Meytal ^a   Fudim, Liza ^a   Weksler Zangen, Sarah ^a   Stodgell, Christopher J ^c   Miller, Richard K ^c   Ornoy, Asher ^a  

^a HEBREW UNIVERSITY   (Israel)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

CDr; CDs; Copper deficiency; Diabetes; Fetal growth restriction; Fetal resorption; FGR; HSD; Oxidative stress; PGD; Rats; RD

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; CATALASE; DRINKING WATER; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MALONALDEHYDE; SUCROSE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; COPPER DEFICIENCY; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; FETUS GROWTH; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; LIVER; NONHUMAN; OXIDATIVE STRESS; PLACENTA DEVELOPMENT; PREGNANCY; RAT;

ANIMALS; CATALASE; COPPER; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FETAL GROWTH RETARDATION; FETUS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; LITTER SIZE; LIVER; MALONDIALDEHYDE; OXIDATIVE STRESS; PREGNANCY; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

ANIMALIA; RATTUS;

EID: 84868459947     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.10.006     Document Type: Article

References (58)

1. Aigner E., Strasser M., Haufe H., Sonnweber T., Hohla F., Stadlmayr A., Solioz M., Tilg H., Patsch W., Weiss G., Stickel F., Datz C. A role for low hepatic copper concentrations in nonalcoholic fatty liver disease. Am. J. Gastroenterol. 2010, 105(9):1978-1985.
2. Airede A.I. Serial copper and ceruloplasmin levels in African newborns with emphasis on the sick and stable preterm infant, and their antioxidant capacities. Early Hum. Dev. 1998, 52:199-210.
3. Al-Saleh E., Nandakumaran M., Al-Shammari M., Makhseed M., Sadan T., Harouny A. Maternal-fetal status of copper, iron, molybdenum, selenium and zinc in insulin-dependent diabetic pregnancies. Arch. Gynecol. Obstet. 2005, 271:212-217.
4. Beckers-Trapp M.E., Lanoue L., Keen C.L., Rucker R.B., Uriu-Adams J.Y. Abnormal development and increased 3-nitrotyrosine in copper-deficient mouse embryos. Free Radic. Biol. Med. 2006, 40:35-44.
5. Bell R., Bailey K., Cresswell T., Hawthorne G., Critchley J., Lewis-Barned N. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG 2008, 115:445-452.
6. Borella P., Szilagyi A., Than G., Csaba I., Giardino A., Facchinetti F. Maternal plasma concentrations of magnesium, calcium, zinc and copper in normal and pathological pregnancies. Sci. Total Environ. 1990, 99:67-76.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
8. Bureau I., Gueux E., Mazur A., Rock E., Roussel A.M., Rayssiguier Y. Female rats are protected against oxidative stress during copper deficiency. J. Am. Coll. Nutr. 2003, 22:239-246.
9. Cecconi D., Lonardoni F., Favretto D., Cosmi E., Tucci M., Visentin S., Cecchetto G., Fais P., Viel G., Ferrara S.D. Changes in amniotic fluid and umbilical cord serum proteomic profiles of foetuses with intrauterine growth retardation. Electrophoresis 2011, 32:3630-3637.
10. Chen H., Carlson E.C., Pellet L., Moritz J.T., Epstein P.N. Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes. Diabetes 2001, 50:2040-2046.
11. Cooper G.J. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease. Drugs 2011, 71:1281-1320.
12. Dai S.Y., Kanenishi K., Ueno M., Sakamoto H., Hata T. Hypoxia-inducible factor-2alpha is involved in enhanced apoptosis in the placenta from pregnancies with fetal growth restriction. Pathol. Int. 2004, 54:843-849.
13. Dosa M.D., Hangan L.T., Crauciuc E., Gales C., Nechifor M. Influence of therapy with metformin on the concentration of certain divalent cations in patients with non-insulin-dependent diabetes mellitus. Biol. Trace Elem. Res. 2011, 142:36-46.
14. Ekmekcioglu C., Prohaska C., Pomazal K., Steffan I., Schernthaner G., Marktl W. Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol. Trace Elem. Res. 2001, 79:205-219.
15. Gambling L., Kennedy C., McArdle H.J. Iron and copper in fetal development. Semin. Cell Dev. Biol. 2011, 22:637-644.
16. Gonzalez M., Reyes-Jara A., Suazo M., Jo W.J., Vulpe C. Expression of copper-related genes in response to copper load. Am. J. Clin. Nutr. 2008, 88:830S-834S.
17. Gybina A.A., Tkac I., Prohaska J.R. Copper deficiency alters the neurochemical profile of developing rat brain. Nutr. Neurosci. 2009, 12:114-122.
18. Haeri S., Khoury J., Kovilam O., Miodovnik M. The association of intrauterine growth abnormalities in women with type 1 diabetes mellitus complicated by vasculopathy. Am. J. Obstet. Gynecol. 2008, 199(278):e271-e275.
19. Hawk S.N., Uriu-Hare J.Y., Daston G.P., Jankowski M.A., Kwik-Uribe C., Rucker R.B., Keen C.L. Rat embryos cultured under copper-deficient conditions develop abnormally and are characterized by an impaired oxidant defense system. Teratology 1998, 57:310-320.
20. Hawk S.N., Lanoue L., Keen C.L., Kwik-Uribe C.L., Rucker R.B., Uriu-Adams J.Y. Copper-deficient rat embryos are characterized by low superoxide dismutase activity and elevated superoxide anions. Biol. Reprod. 2003, 68:896-903.
21. Hebert C.D., Elwell M.R., Travlos G.S., Fitz C.J., Bucher J.R. Subchronic toxicity of cupric sulfate administered in drinking water and feed to rats and mice. Fundam. Appl. Toxicol. 1993, 21:461-475.
22. Hyvonen-Dabek M., Nikkinen-Vilkki P., Dabek J.T. Selenium and other elements in human maternal and umbilical serum, as determined simultaneously by proton-induced X-ray emission. Clin. Chem. 1984, 30:529-533.
23. Ito S., Fujita H., Narita T., Yaginuma T., Kawarada Y., Kawagoe M., Sugiyama T. Urinary copper excretion in type 2 diabetic patients with nephropathy. Nephron 2001, 88:307-312.
24. Jawerbaum A., Higa R., White V., Capobianco E., Pustovrh C., Sinner D., Martinez N., Gonzalez E. Peroxynitrites and impaired modulation of nitric oxide concentrations in embryos from diabetic rats during early organogenesis. Reproduction 2005, 130:695-703.
25. Lewis S.M., U.D., Barnard D.E., Knapka J.J. Nutrition in the laboratory rat. The Laboratory Rat 2006, 219-301. Academic Press, San Diego, CA. M.A. Suckow, S.H. Weisbroth, C.L. Franklin (Eds.).
26. Markowitz H., Gubler C.J., Mahoney J.P., Cartwright G.E., Wintrobe M.M. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome. J. Clin. Invest. 1955, 34:1498-1508.
27. McCord J.M., Fridovich I. Superoxide dismutase: the first twenty years (1968-1988). Free Radic. Biol. Med. 1988, 5:363-369.
28. Mihara M., Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978, 86:271-278.
29. Miyajima H., Takahashi Y., Kono S., Sugimoto M., Suzuki Y., Hishida A., Sakamoto M., Ouchi Y. Glucose and oxygen hypometabolism in aceruloplasminemia brains. Intern. Med. 2002, 41:186-190.
30. National Research Council (U.S.).Subcommittee on the Tenth Edition of the RDAs, National Institutes of Health (U.S.), National Research Council (U.S.).Committee on Dietary Allowances Recommended Dietary Allowances 1989, National Academy Press, Washington, D.C.
31. Nelson K.T., Prohaska J.R. Copper deficiency in rodents alters dopamine beta-mono-oxygenase activity, mRNA and protein level. Br. J. Nutr. 2009, 102:18-28.
32. Nicholson J.R., Savory M.G., Savory J., Wills M.R. Micro-quantity tissue digestion for metal measurements by use of a microwave acid-digestion bomb. Clin. Chem. 1989, 35:488-490.
33. Ornoy A., Tsadok M.A., Yaffe P., Zangen S.W. The Cohen diabetic rat as a model for fetal growth restriction: vitamins C and E reduce fetal oxidative stress but do not restore normal growth. Reprod. Toxicol. 2009, 28:521-529.
34. Ornoy A., Rand S.B., Bischitz N. Hyperglycemia and hypoxia are interrelated in their teratogenic mechanism: studies on cultured rat embryos. Birth Defects Res. B Dev. Reprod. Toxicol. 2010, 89:106-115.
35. Ornoy A., Livshitz A., Ergaz Z., Stodgell C.J., Miller R.K. Hyperglycemia, hypoxia and their combination exert oxidative stress and changes in antioxidant gene expression: studies on cultured rat embryos. Birth Defects Res. B Dev. Reprod. Toxicol. 2011, 92:231-239.
36. Ryu S., Kohen R., Samuni A., Ornoy A. Nitroxide radicals protect cultured rat embryos and yolk sacs from diabetic-induced damage. Birth Defects Res. A Clin. Mol. Teratol. 2007, 79:604-611.
37. Ryu S., Ornoy A., Samuni A., Zangen S., Kohen R. Oxidative stress in Cohen diabetic rat model by high-sucrose, low-copper diet: inducing pancreatic damage and diabetes. Metabolism 2008, 57:1253-1261.
38. Salimonu L.S. Acute phase proteins in "small for dates" babies. II. Haptoglobin, transferrin, alpha-1-feto protein, alpha-1-acid glycoprotein and caeruloplasmin levels. Afr. J. Med. Med. Sci. 1992, 21:55-59.
39. Shah M.D., Shah S.R. Nutrient deficiencies in the premature infant. Pediatr. Clin. North Am. 2009, 56:1069-1083.
40. Sitasawad S., Deshpande M., Katdare M., Tirth S., Parab P. Beneficial effect of supplementation with copper sulfate on STZ-diabetic mice (IDDM). Diabetes Res. Clin. Pract. 2001, 52:77-84.
41. Speich M., Murat A., Auget J.L., Bousquet B., Arnaud P. Magnesium, total calcium, phosphorus, copper, and zinc in plasma and erythrocytes of venous cord blood from infants of diabetic mothers: comparison with a reference group by logistic discriminant analysis. Clin. Chem. 1992, 38:2002-2007.
42. Sugioka K., Shimosegawa Y., Nakano M. Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett. 1987, 210:37-39.
43. Talaei A., Jabari S., Bigdeli M.H., Farahani H., Siavash M. Correlation between microalbuminuria and urinary copper in type two diabetic patients. Indian J. Endocrinol. Metab. 2011, 15:316-319.
44. Taneja S.K., Mahajan M., Gupta S., Singh K.P. Assessment of copper and zinc status in hair and urine of young women descendants of NIDDM parents. Biol. Trace Elem. Res. 1998, 62:255-264.
45. Thurman R.G., Ley H.G., Scholz R. Hepatic microsomal ethanol oxidation. Hydrogen peroxide formation and the role of catalase. Eur. J. Biochem. 1972, 25:420-430.
46. Tumer Z., Moller L.B. Menkes disease. Eur. J. Hum. Genet. 2010, 18:511-518.
47. Uriu-Adams J.Y., Keen C.L. Copper, oxidative stress, and human health. Mol. Aspects Med. 2005, 26:268-298.
48. Uriu-Adams J.Y., Scherr R.E., Lanoue L., Keen C.L. Influence of copper on early development: prenatal and postnatal considerations. Biofactors 2010, 36:136-152.
49. Weksler-Zangen S., Yagil C., Zangen D.H., Ornoy A., Jacob H.J., Yagil Y. The newly inbred cohen diabetic rat: a nonobese normolipidemic genetic model of diet-induced type 2 diabetes expressing sex differences. Diabetes 2001, 50:2521-2529.
50. Weksler-Zangen S., Yaffe P., Ornoy A. Reduced SOD activity and increased neural tube defects in embryos of the sensitive but not of the resistant Cohen diabetic rats cultured under diabetic conditions. Birth Defects Res. A Clin. Mol. Teratol. 2003, 67:429-437.
51. Williams N.R., Rajput-Williams J., West J.A., Nigdikar S.V., Foote J.W., Howard A.N. Plasma, granulocyte and mononuclear cell copper and zinc in patients with diabetes mellitus. Analyst 1995, 120:887-890.
52. Yang S.J., Keen C.L., Lanoue L., Rucker R.B., Uriu-Adams J.Y. Low nitric oxide: a key factor underlying copper-deficiency teratogenicity. Free Radic. Biol. Med. 2007, 43:1639-1648.
53. Zadrozna M., Gawlik M., Nowak B., Marcinek A., Mrowiec H., Walas S., Wietecha-Posluszny R., Zagrodzki P. Antioxidants activities and concentration of selenium, zinc and copper in preterm and IUGR human placentas. J. Trace Elem. Med. Biol. 2009, 23:144-148.
54. Zangen S.W., Yaffe P., Shechtman S., Zangen D.H., Ornoy A. The role of reactive oxygen species in diabetes-induced anomalies in embryos of Cohen diabetic rats. Int. J. Exp. Diabetes Res. 2002, 3:247-255.
55. Zangen S.W., Ryu S., Ornoy A. Alterations in the expression of antioxidant genes and the levels of transcription factor NF-kappa B in relation to diabetic embryopathy in the Cohen diabetic rat model. Birth Defects Res. A Clin. Mol. Teratol. 2006, 76:107-114.
56. Zhang X., Ruiz B., Correa P., Miller M.J. Cellular dissociation of NF-kappaB and inducible nitric oxide synthase in Helicobacter pylori infection. Free Radic. Biol. Med. 2000, 29:730-735.
57. Ziaei S., Norrozi M., Faghihzadeh S., Jafarbegloo E. A randomised placebo-controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin > or = 13.2 g/dl. BJOG 2007, 114:684-688.
58. Zusman I., Ornoy A. The effects of maternal diabetes and high sucrose diets on the intrauterine development of rat fetuses. Diabetes Res. 1986, 3:153-159.